Document Page: First | Prev | Next | All | Image | This Release | Search
File: 120396_sep96_decls82_0001.txt
Subject: PLAN FOR PROTECTION OF THE ARMY FORCE AGAINST ENDEMIC
Unit: OTSG
Parent Organization: HSC
Box ID: BX003203
Folder Title: PLAN FOR PROTECTION OF THE ARMY FORCE AGAINST ENDEMIC DISEASES
Document Number: 1
Folder SEQ #: 96
,OL
12 Jul 90
DRAFT
PLAN FOR PROTECTION OF THE ARMY FORCE
AGAINST ENDEMIC DISEASES AND BIOLOGICAL WARFARE AGENTS
WITH CONTINGENCY VACCINES, TOXOIDS, AND IMMUNE GLOBULIN*
1. Purpose. The purpose of the vaccination plan is to ensure that
Army personnel are provided the maximum protection against endemic
diseases and biological warfare (BW) agent threats in low, mid, and
high intensity conflicts and potential-terrorist situations.
2. objectives.
a. Delineate responsibilities and procedures for the
acquisition, storage, quality assurance and administration of
vaccines, toxoids, and/or immune globulins to U.S. Army forces.
b. Establish the operational structure within the Office of
The Surgeon General, U.S. Army, that will allow for a periodic
review of the indications for the use of certain vaccines, and a
determination of how such products would be distributed and
administered in a timely fashion.
C. Ensure that the contingency vaccines against known military
threats will be readily available to individuals and units on short
notice.
d. Ensure that an industrial base for production of these
products is adequate to meet requirements beyond contingeny needs.
3. Background.
a. AR 40-562, Immunizations and Chemoprophylaxis, is a
tri-service regulation that describes policies, procedures, and
responsibilities for immunization and chemoprophylaxis. It defines
immunization requirements for Army active duty and Reserve
personnel and their dependents and Federal civilian employees and
their dependents serving, traveling, or residing under cognizance
of the military or utilizing facilities at military activities.
vaccines and chemoprophylactic agents covered by this
AR are licensed by the Food and Drug Administration (FDA) and are
commercially available.
b. The contingency vaccine stockpile includes vaccines,
toxoids, and immune globulins which are in the investigational new
drug (IND) phase of testing and have not received licensure by the
FDA. Therefore, administration of these products would, under
ordinary circumstances, require voluntary consent. In times of
*Reference to vaccines in text also includes d@,an@d'.tmmilne-
globulins.
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 13 f:/Week-36/BX003203/PLAN FOR PROTECTION OF THE ARMY FORCE AGAINST ENDEMIC DISEASES/plan for protection of the army force against en:11259610132722
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = PLAN FOR PROTECTION OF THE ARMY FORCE AGAINST ENDEMIC DISEASES
Folder Seq # = 96
Subject = PLAN FOR PROTECTION OF THE ARMY FORCE AGAINST EN
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 25-NOV-1996